1. Kalra Ajay
2. Vashishtha Vipin M

9789350252468

10.5005/jp/books/11414_30

1/e

2011

8

1. SN Medical College, Agra; Rural Institute of Medical Sciences, Saifai, Uttar Pradesh, India
2. Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices; , Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India, National Convener, IAP Committee on Immunization, 2011-13, Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India, Mangla Hospital and Research Center, Bijnor, Uttar Pradesh, India; Indian Academy of Pediatrics Advisory Committee on Vaccines and Immunization Practices

Dengue, transient partial cross protection, 4 DV serotypes, heterotypic DV antibodies, in vitro correlate of protection, DHF, DSS, live attenuated virus, chimeric live attenuated virus vaccine, live recombinant DNA and subunit vaccines, inactivated vaccines, humoral and cellular immune response, plaque phenotype, thermosensitivity, in vivo attenuation, immunological interference, DEN3 GMK33-FRhL-2 virus, DVBID, WRAIR, homotypic chimeric virus, heterotypic chimeric viruses, YFV genome, DEN-YF chimeras, recombinant DNA vaccine, Biojector device, Naval Medical Research Center, nonreplicative adenovirus vector, pediatric dengue vaccine